IHA’s Anne Lee Amarnath, MD, MPH, Selected for DMHC Health Equity and Quality Committee
OAKLAND, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- The Integrated Healthcare Association (IHA) announced today that Anna Lee Amarnath, MD,...
Month: February 2022
Avelead Announces Expansion of Leadership Team
Sykes and Yzerman to Lead Innovation and Services Departments Atlanta, Georgia, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Avelead, a Streamline...
Mustang Bio Selected as a Bronze Winner in Eighteenth Annual Team Massachusetts Economic Impact Awards
WORCESTER, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on...
Satsuma Pharmaceuticals to Present at the Virtual 11th Annual SVB Leerink Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company developing...
Intrommune Reports Positive Update from Ongoing Phase 1 Study in Peanut Allergy
INT301 Met Safety Goals Across Four Dose Levels in Cohort 1 Patient Treatment Now Ongoing in Fully Enrolled Cohort 2...
HealthEC Receives 2022 Best in KLAS Award for Population Health Management
Population health management industry leader recognized receives top honor with high marks in customer satisfaction and loyalty in the annual...
Outlook Therapeutics Expands Commercial Team with Appointment of Senior Vice President of Commercial Operations
Joel Prieve brings nearly 20 years of commercial operations expertise and proven track record in sales and account managementISELIN, N.J.,...
Vistin Pharma ASA: Invitation to Q4 2021 conference call
Oslo, Norway, 8 February 2022 Vistin Pharma ASA will release its fourth quarter 2021 results on Thursday 17th of February 2022....
Route 92 Medical® Announces First Patient Enrollment in the SUMMIT MAX Pivotal Clinical Trial for the Monopoint® Reperfusion System
SAN MATEO, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a private medical technology company dedicated to...
Eyenovia Concludes Type A Meeting with FDA Related to MydCombi™ NDA Resubmission
No additional clinical work required; NDA resubmission anticipated in Q3 2022NEW YORK, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Eyenovia, Inc....
Healx and Ovid Therapeutics to Enter Strategic Partnership
– Ovid to License Gaboxadol to Healx – – Healx to Explore Gaboxadol in Combination Therapies for Fragile X, Other...
Hyperfine Appoints Chip Truwit, M.D. as Senior Medical Director
Creators of the world’s first FDA-cleared portable MRI scales executive team for its next phase of development Dr. Chip Truwit,...
NextCure to Present at 11th Annual SVB Leerink Global Healthcare Conference
BELTSVILLE, Md., Feb. 08, 2022 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and...
Beyond Air® Announces Participation at Upcoming Investor Conferences in March 2022
GARDEN CITY, N.Y., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical...
Soleno Therapeutics to Participate in the BIO CEO & Investor Conference
REDWOOD CITY, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing...
Salarius Pharmaceuticals to Participate in the 2022 BIO CEO & Investor Conference
HOUSTON, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines...
Palisade Bio (Nasdaq: PALI) to Announce Adhesions Clinical Data at SAGES 2022 Annual Meeting
Incidence and Severity of Post-Surgical Intraabdominal Adhesions following Bowel Resection Surgery and Treatment with Enteral Protease Inhibitor LB1148CARLSBAD, Calif., Feb....
Frontier Medicines Announces Renowned Physician Scientist Piro Lito, M.D., Ph.D., Joins Scientific Advisory Board
SOUTH SAN FRANCISCO, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock...
GelStat Announces $5 Million Public Offering Under Regulation A+
GelStat Corporation Has Been Qualified by the SEC for a Regulation A+ Public OfferingSTUART, Fla., Feb. 08, 2022 (GLOBE NEWSWIRE)...
Werewolf Therapeutics to Present at the SVB Leerink Global Healthcare Conference
CAMBRIDGE, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical...
